Perception of Hormonal Replacement Therapy Among Patients Aged 11 to 17 Years

To establish a current knowledge and perception of patients and their parents regarding HRT in order to assess the needs that can promote understanding and adherence to treatment by implementing therapeutic education workshops

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Female Hypogonadism Endocrine System Diseases Gonadal Disorders Hypogonadism

Age range

11 year–18 year

Sex eligibility

Female

Study type

Observational

Primary location

Service de Gynécologie et obstétrique - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Female patients aged 11 to 18 years
Treated at the University Hospital of Strasbourg for central or peripheral hypogonadism with the initiation of hormone replacement therapy

Exclusion criteria

Inability to provide the subject with clear information (difficulties understanding the subject, language barrier, illiteracy, etc.)

Treatment and study plan

Primary outcomes

Assessment of patients' knowledge about the composition of hormonal treatment for female hypogonadism

Time frame: Up to 7 months

The aim is to assess the knowledge of patients aged 11 to 18 about the composition of hormone treatment for female hypogonadism using a questionnaire.
Assessment of patients' knowledge regarding the effects of hormonal treatment for female hypogonadism

Time frame: Up to 7 months

The aim is to assess the knowledge of patients aged 11 to 18 years about the effects of hormone treatment for female hypogonadism using a questionnaire.

Interested in participating?

Recruiting

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Official study title

Current Knowledge and Perceptions of Hormone Replacement Therapy Among Patients Aged 11 to 18 Years, and Their Parents, Treated for Hypogonadism at the Strasbourg University Hospital

Acronym: THS

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: Jan 5, 2026
Registry last updated: Jan 5, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, not recruiting